<DOC>
	<DOCNO>NCT01343368</DOCNO>
	<brief_summary>Women undergo myeloablative allogeneic hematopoietic cell transplant ( MA HCT ) receive GnRH agonist leuprolide . Women undergo reduced intensity allogeneic ( RIC ) HCT observe .</brief_summary>
	<brief_title>Preservation Ovarian Function After Hematopoietic Cell Transplant</brief_title>
	<detailed_description>This study use gonadotropin release hormone ( GnRH ) agonist leuprolide prior myeloablative hematopoietic cell transplantation prevent ovarian dysfunction post-menarchal woman . The primary objective determine effect GnRH agonists incidence ovarian failure . The secondary objective - determine effective GnRH agonist suppress menses - determine incidence time resumption menstrual cycle HCT - determine incidence time resumption normal FSH LH level HCT - determine incidence normal AMH level HCT - determine effect GnRH agonists immune reconstitution HCT - ass safety tolerability GnRH agonists context HCT A total 47 patient accrue study .</detailed_description>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Hodgkin Disease</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Leuprolide</mesh_term>
	<criteria>Interventional Arm : Eligible myeloablative allogenic autologous hematopoietic cell transplant ( HCT ) Postmenarchal female &lt; = 50 year age Normal antimullerian hormone ( AMH ) level and/or follicle stimulate hormone ( FSH ) /leuprolide ( LH ) level age/stage puberty Those woman FSH &gt; 40 IU/L whose diagnosis malignancy whose chemotherapy treatment within 12 week enrollment still eligible normal menstrual cycle prediagnosis . Observational Arm : Eligible reduced intensity allogeneic HCT Postmenarchal female â‰¤ 50 year age Normal AMH level and/or FSH/LH age/stage puberty Those woman FSH &gt; 40 IU/L whose diagnosis malignancy chemotherapy treatment within 12 week enrollment still eligible normal menstrual cycle prediagnosis . All Arms : History ovarian cancer Surgical resection one ovary . Prior hysterectomy allow long ovary intact . Use GnRH agonist last 12 month exclude patient lab result available demonstrate adequate ovarian function prior initiation GnRH therapy .</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Post-menarchal</keyword>
</DOC>